Further improve the reporting quality of clinical research in China_Chinese Journal of Evidence-Based Medicine

Authors：

 BIAN Zhaoxiang ^1,2 , LI Youping ³ , David Moher ⁴

1. School of Chinese Medicine, Hong Kong Baptist University, HongKong 999077, P.R.China;
2. Chinese EQUATOR Center, HongKong 999077, P.R.China;
3. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P.R.China;
4. University of Ottawa, Ottawa KIN 6N5, Canada;

Corresponding?author：

BIAN Zhaoxiang, Email: bianzxiang@gmail.com

Keywords：

DOI：

10.7507/1672-2531.202009123

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： BIAN Zhaoxiang, LI Youping, David Moher. Further improve the reporting quality of clinical research in China. Chinese Journal of Evidence-Based Medicine, 2020, 20(12): 1365-1366. doi: 10.7507/1672-2531.202009123 Copy

1.	Ioannidis JPA. Why most clinical research is not useful. PLoS Med, 2016, 13(6): e1002049.
2.	Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 1996, 276(8): 637-639.
3.	Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
4.	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 2009, 6(7): e1000097.
5.	Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med, 2007, 147(8): 573-577.
6.	Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet, 2014, 383(9913): 267-276.
7.	Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med, 2013, 2(5): 38-43.
8.	劉玉秀, 姚晨, 陳峰, 等. 隨機對照臨床試驗報告格式 CONSORT 介紹. 中華男科學, 2001, 7(5): 288-291.
9.	Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med, 2017, 167(2): 112-121.
10.	Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (Traditional Chinese Version). Ann Intern Med, 2017, 167(2): W7-W20.
11.	Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (Simplified Chinese Version). Ann Intern Med, 2017, 167(2): W21-W34.

1. Ioannidis JPA. Why most clinical research is not useful. PLoS Med, 2016, 13(6): e1002049.
2. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 1996, 276(8): 637-639.
3. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
4. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 2009, 6(7): e1000097.
5. Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med, 2007, 147(8): 573-577.
6. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet, 2014, 383(9913): 267-276.
7. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med, 2013, 2(5): 38-43.
8. 劉玉秀, 姚晨, 陳峰, 等. 隨機對照臨床試驗報告格式 CONSORT 介紹. 中華男科學, 2001, 7(5): 288-291.
9. Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med, 2017, 167(2): 112-121.
10. Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (Traditional Chinese Version). Ann Intern Med, 2017, 167(2): W7-W20.
11. Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (Simplified Chinese Version). Ann Intern Med, 2017, 167(2): W21-W34.

Next Article
Ethical challenges of precision medicine in China

Chinese Journal of Evidence-Based Medicine

Further improve the reporting quality of clinical research in China

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content